Skip to main content
Premium Trial:

Request an Annual Quote

Molecular Profiles, Xceleron Partner to Use ASM Technology in Drug Development

NEW YORK (GenomeWeb) – Molecular Profiles and Xceleron today announced a collaboration to help drug developers improve efficiency during the clinical development stage.

Xceleron's knowledge in using accelerator mass spectrometry technology in pharma applications will be added to Molecular Profiles' new Roadmap to Clinical Trials platform, launched earlier this month. The screening platform incorporates Molecular Profiles' existing formulation and analytical development modules to streamline the development of drugs.

The deal aims to improve the quality and accuracy of clinical data and to support early proof-of-concept research in order to "assist drug innovators with more assured translation," the partners said in a statement.

"Looking at Molecular Profiles' Roadmap to Clinical Trials platform, we believe there is an opportunity to add our complementary analytical technology to the process," Xceleron CEO Michael Butler said. "This gives our clients the option to investigate the impact of solid state and formulations on human disposition at a very early stage."
Based in Nottingham, UK, Molecular Profiles is a subsidiary of Columbia Laboratories. It is a contract development and manufacturing organization specializing in early phase pharmaceutical development.

Xceleron provides analytical services based on accelerator mass spec technology, primarily for pharma R&D. It is headquartered in Germantown, Md.

Financial and other terms of the deal were not disclosed.

The Scan

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.

Researchers Model Microbiome Dynamics in Effort to Understand Chronic Human Conditions

Investigators demonstrate in PLOS Computational Biology a computational method for following microbiome dynamics in the absence of longitudinally collected samples.

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.